[1] 孙婉璐,曹海霞,范建高.非酒精性脂肪性肝病的诊断与治疗.中华肝脏病杂志,2014,22:705-707.
[2] Team R, Labrecque DR, Abbas Z, et al. World Gastro-enterology Organisation Global Guidelines: Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. J Clin Gastro-enterol, 2014, 30: 467-473.
[3] Morio K, Imamura M, Daijo K, et al. Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury. J Gastroenterol, 2017, 52: 1-6.
[4] 王伟,马玉萍,马海婷,等.血清M2BPGi联合MRI-DWI预测丙型肝炎患者肝纤维化的临床价值.实用医学杂志,2018,34:293-296.
[5] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2010年修订版).胃肠病学和肝病学杂志,2010,19:483-487.
[6] Zimmermann E, Gamborg M, Holst C, et al. Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register. Bmj Open, 2015, 5: e006998.
[7] 郑永才,陈亮,路富林,等.运动疗法治疗非酒精性脂肪肝的临床疗效观察.肝脏,2015, 20:51-53.
[8] Fujiyoshi M, Kuno A, Gotoh M, et al. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma. J Gastro-enterol, 2015, 50: 1134-1144.
[9] Nagata H, Nakagawa M, Nishimura-Sakurai Y, et al. Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy. Hepatol Int, 2016, 10: 1-9.
[10] 闫琪.血清紫花滕凝集素阳性MAC-2结合蛋白比MAC-2结合蛋白更能可靠区分非酒精性脂肪性肝病的肝纤维化阶段.临床肝胆病杂志,2018,34:552-552. |
